Breast Cancer News

Treatment with anthracyclines for breast cancer or lymphoma correlated with more than two times higher risk for congestive heart failure than that of healthy controls, according to a study conducted at Mayo Clinic.

Mary B. Daly, MD, PhD, FACP, has been named the inaugural recipient of the BRCA Impact Award, presented by Penn Medicine’s Basser Center for BRCA.

The FDA announced several regulatory actions the past few weeks.

A nurse-led cancer genetics program embedded within an oncology clinic appeared associated with a significant increase in genetic testing rates vs. a telegenetics service among Black veterans, according to a study in JCO Oncology Practice.

Underrepresented groups face elevated cardiotoxic risk and strategies are needed to eliminate inequities in cardio-oncology research and clinical care, according to a scientific statement published in Circulation.

So far in 2023, there has been an overwhelming shortage of chemotherapy drugs, of which several specifically impact gynecologic oncology providers and patients.

Sara A. Hurvitz, MD, has been appointed senior vice president of the clinical research division at Fred Hutchinson Cancer Center.

High allostatic load appeared associated with increased risk for all-cause mortality among patients with breast cancer, according to study results published in JAMA Network Open.

In this episode, host Shikha Jain, MD, speaks with Medidata’s Alicia Staley about enhancing the patient care experience from a former patient’s perspective, building empathetic technical solutions and more.

FDA announced the creation of a voluntary pilot program that will assist clinicians in selecting the appropriate treatment for patients with cancer through the use of laboratory-developed tests, according to an FDA press release.